EUVIMEDEUVIMED entdecken
Crossref

Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice

Lei Guo, Shuzhuo Wang, Haihua Tian, Mengyuan Shang, Jia Xu, Chuang Wang

Cerebral Cortex · 2023

DOI: 10.1093/cercor/bhad299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebral Cortex, 2023. Verfasst von Lei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China. Hauptthemen laut MEDLINE: Receptors, AMPA, Prefrontal Cortex, Glycogen Synthase Kinase 3 beta, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Funds for Distinguished Young Scholar of Zhejiang, National Natural Science Foundation of China, Municipal Key Research and Development Program of Ningbo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous evidence has suggested a vital role of glycogen synthase kinase 3β-mediated α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors trafficking in depression. Considering the antidepressant effect of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors activation in the prefrontal cortex, we hypothesized that glycogen synthase kinase 3β-induced alterations in α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors function in the prefrontal cortex participate in depression. Herein, we confirmed that the levels of phosphorylated glycogen synthase kinase 3β and GluA1, the latter being a subunit of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, were decreased in the prefrontal cortex of the chronic social defeat stress model mice presenting with depressive-like behaviors. We then found that a glycogen synthase kinase 3β (p.S9A) point mutation downregulated GluA1 and induced depressive-like behaviors in mice, whereas an agonist of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, PF-4778574 (2 mg/kg) did not reversed the molecular changes. On the other hand, the antidepressant effect of PF-4778574 was dose dependent, and the single administration of PF-4778574 at a lower dose (0.5 mg/kg) or of the glycogen synthase kinase 3β inhibitor SB216763 (5 and 10 mg/kg) did not evoke an antidepressant effect. In contrast, co-treatment with PF-4778574 (0.5 mg/kg) and SB216763 (10 mg/kg) led to antidepressant effects similar to those of PF-4778574 (2 mg/kg). Our results suggest that glycogen synthase kinase 3β-induced α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors dysfunction in the prefrontal cortex is one of the key mechanisms of depression, and the combination of a lower dose of PF-4778574 with SB216763 shows potential as a novel synergistic treatment for depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AMPAPrefrontal CortexGlycogen Synthase Kinase 3 betaDepressionAntidepressive AgentsAnimalsMiceMaleMice, Inbred C57BLMaleimidesIndolesSocial DefeatDrug SynergismDisease Models, Animal

Stichwörter der Autor:innen

GSK3βmajor depressive disorder (MDD)α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPARs)

Substanzen

Receptors, AMPAGlycogen Synthase Kinase 3 betaAntidepressive AgentsMaleimidesSB 216763IndolesGsk3b protein, mouse

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China.
  • School of Basic Medical Science, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China.
  • Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang 315201, PR China.

Förderung

  • Natural Science Funds for Distinguished Young Scholar of Zhejiang
  • National Natural Science Foundation of China
  • Municipal Key Research and Development Program of Ningbo
  • Ningbo Natural Science Foundation

Zitieren

APA

Guo, L., Wang, S., Tian, H., Shang, M., Xu, J., & Wang, C. (2023). Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice. Cerebral Cortex. https://doi.org/10.1093/cercor/bhad299

Vancouver

Guo L, Wang S, Tian H, Shang M, Xu J, Wang C. Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice. Cerebral Cortex. 2023. doi:10.1093/cercor/bhad299

BibTeX
@article{Guo2023,
  author = {Guo, Lei and Wang, Shuzhuo and Tian, Haihua and Shang, Mengyuan and Xu, Jia and Wang, Chuang},
  title = {Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice},
  journal = {Cerebral Cortex},
  year = {2023},
  doi = {10.1093/cercor/bhad299}
}
Kostenlos starten →